How did BIOX's revenue and expenses trend in Q2 2025 compared to previous quarters?

Bioceres Crop (BIOX) showed a significant decline in revenue and an increase in expenses in Q2 2025 compared to the previous quarter, Q4 2023. 1. **Revenue Trend**: - In Q4 2023, BIOX reported a total revenue of $140.22 million. - In Q2 2025, the total revenue dropped to $93.29 million. - This indicates a decrease in revenue of approximately 33.5% from Q4 2023 to Q2 2025. 2. **Expense Trend**: - The total expenses for Q4 2023 are not available. - However, the absence of expense data in Q2 2025 does not necessarily imply zero expenses, only that the data is not currently available. 3. **Comparison and Insights**: - The decline in revenue from $140.22 million in Q4 2023 to $93.29 million in Q2 2025 is substantial and could indicate a challenging period for the company. - The increase in expenses would typically be a concern if it were not accompanied by a corresponding increase in revenue. Without expense data for Q2 2025, it is not possible to assess the full financial health of the company during this period. BIOX Revenue, Expenses in Q3 2024 |code|Ticker|Name|Last Price|Last Change|Report End Date|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---|---|---|---| |BIOX|BIOX.O|Bioceres Crop|4.44|8.029197|20240930|2024 Q3|9.3287253E7||185| BIOX Revenue, Expenses in Q4 2023 |code|Ticker|Name|Last Price|Last Change|Report End Date|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---|---|---|---| |BIOX|BIOX.O|Bioceres Crop|4.44|8.029197|20231231|2023 Q4|1.40221042E8||185|